Subscribe to our RSS feeds RSS | Login | Register  
 

Latest News

Declining ad rates close two CMPMedica titles

Declining ad rates close two CMPMedica titles

Ben Comer July 02, 2009

CMPMedica ceased to publish two of its titles - Infections in Medicine and AIDS Reader - due to a continuing decline in print advertising sales.
 

Roche coaches docs, RNs on diabetes care

Ben Comer July 01, 2009

Roche added a new component to its $14 million diabetes education campaign, which pairs healthcare practitioners with Roche staff to improve dialogue between diabetics and their caregivers, and facilitate the integration of Accu-Check products into the lives of patients.
 

Sanofi-Aventis announces R&D restructuring

Ben Comer June 30, 2009

Sanofi-Aventis announced plans to restructure its R&D model, set to be completed by 2013.
 
Supreme Court shrugs at NH data ban

Supreme Court shrugs at NH data ban

Ben Comer June 30, 2009

The Supreme Court will not take on a New Hampshire data ban enacted in 2006, overturned 10 months later by a district court, and then reinstated by a federal appeals court last November.
 
AstraZeneca unbranded effort urges sufferers to "Rethink COPD"

AstraZeneca unbranded effort urges sufferers to "Rethink COPD"

Matthew Arnold June 29, 2009

AstraZeneca is rolling out an unbranded COPD education campaign featuring comedian and actor Robert Klein.
 

FDA warns Takeda about Velcade reminder

Ben Comer June 26, 2009

FDA took issue with a professional mailer and detachable card used at the recent ASCO conference, calling the reminder labeling inappropriate. The ad also overstated the efficacy of Velcade, according to the letter.
 

J&J exec says "public plan" would stymie innovation

Anthony Vecchione June 25, 2009

Kathleen Buto, vice president, health policy, for Johnson & Johnson told a congressional committee the pharmaceutical industry is concerned a public health plan could undermine a market-based system that provides incentives for long-term research
 

Lawmakers eyeing tax deductions on drug ads

Matthew Arnold June 24, 2009

Drug and advertising industry advocates are sounding the alarm over congressional threats to tax drug advertising.
 

Bayer work a blueprint for new consumer health site

Ben Comer June 23, 2009

DazMedia hopes to leverage its interactive work with Bayer on Betaseron, an MS treatment, into other product and condition areas for a new website: Real World Health. The site is expected to launch during the third quarter, and may include condition areas such as Alzheimer's, diabetes and/or HIV.
 

PhRMA pledges $80 billion in discounts towards health reform cost-cutting

Matthew Arnold June 22, 2009

PhRMA has committed to finding $80 billion in savings on drugs sold in the US over ten years, including selling drugs at half-price to seniors in the Medicare Part D "donut hole" coverage gap.
 

MM&M New Drug Dossier

MM&M's New Drug Dossier combines promotional insights with clinical information to offer marketers the first complete online resource for newly approved drugs. Click here to sign up for a year's subscription at the special introductory rate of $275 and get unlimited access to the MM&M New Drug Dossier online archive and email alerts.

Latest Issue

The Agency Issue

The most objective and independent guide to healthcare agencies, with up-close profiles of the Top 75

Latest Features

The Top 75: AbelsonTaylor

The Top 75: AgencyRx

The Top 75: Area 23

The Top 75: Beacon Healthcare Communications

The Top 75: Blue Diesel

The Top 75: Brand Pharm

 Subscribe to the RSS for this page  [view all our RSS feeds here]
Popular Topics
Advertising Agency Biotech Brand Consumer CRM Digital Direct Marketing Direct To Patient (DTP) Education & Awareness Event Government Magazine Marketing & Communications Media Medical Journal Online Pharmaceutical Product Professional Promotion Public Relations (PR) Sales Force Suppliers & Vendors Television